Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-06-18 @ 9:08 AM
Study NCT ID:
NCT00725634
Status:
COMPLETED
Last Update Posted:
2014-01-27
First Post:
2008-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Neoplasms, | View |
| None | Lymphoma, | View |
| None | Multiple Myeloma, | View |
| None | Neoplasms, Plasma Cell, | View |
| None | Neoplasms by Histologic Type, | View |
| None | Lymphoproliferative Disorders, | View |
| None | Lymphatic Diseases, Immunoproliferative Disorders | View |
| None | Immune System Diseases Hemostatic Disorders | View |
| None | Vascular Diseases | View |
| None | Cardiovascular Diseases | View |
| None | Paraproteinemias | View |
| None | Blood Protein Disorders | View |
| None | Hematologic Diseases | View |
| None | Hemorrhagic Disorders | View |
| None | Erlotinib | View |
| None | Protein Kinase Inhibitors | View |
| None | Enzyme Inhibitors, | View |
| None | Molecular Mechanisms of Pharmacological Action | View |
| None | Pharmacologic Actions | View |